Can systemic parenteral ozone therapy generate biological ozone? A new hypothesis

Maritza F. Díaz-Gómez, Frank Hernández-Rosales

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)


Since the first years of this century, evidence of the generation of singlet oxygen and endogenous ozone from antibodies and some amino acids has been reported. Different mechanisms of action have been proposed which provide appropriate pathways that scientifically justify their approval. On the other hand, parenteral systemic ozone therapy is known to produce reactive oxygen species (ROS) that by chemical interconversion could form singlet oxygen, which is the precursor to trigger the formation of endogenous ozone. This article analyzes the latest evidences reported on the generation of biological ozone, and highlights the hypothesis that ROS resulting from the application of parenteral ozone therapy can also lead to the endogenous formation of ozone or an oxidant like ozone. Future confirmation of this approach would be another justification for the usefulness of ozone therapy in the treatment of diseases such as viral ones and antibiotic resistance.

Original languageEnglish
Article number100063
JournalAdvances in Redox Research
Publication statusPublished - Apr 2023


  • Amino acid oxidation pathway
  • Antibody oxidation pathway
  • Biological ozone, biological singlet oxygen
  • Endogenous ozone
  • Ozone therapy
  • Water oxidation pathway

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology (miscellaneous)


Dive into the research topics of 'Can systemic parenteral ozone therapy generate biological ozone? A new hypothesis'. Together they form a unique fingerprint.

Cite this